Using bladder cancer cell lines, we have shown that VFL treatment induces cell death in bladder cancer cells and activates epithelial differentiation in the remaining cells, leading to increased E-cadherin-dependent cell-cell adhesions and to reduced levels of mesenchymal markers, such as N-cadherin or vimentin. This evidence concerns the gene CDH2 and urinary bladder carcinoma.